Preventative Maintenance/Service Contract for Seventeen (17) ChemoMetec NC-202 Instruments
Closed Pre-Solicitation Posted
- Solicitation number
- 26-007432
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 811210 Electronic and Precision Equipment Repair and Maintenance
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
-
- Shasheshe Goolsby shasheshe.goolsby@nih.gov (301) 827-4879
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health Clinical Center intends to award a sole-source firm-fixed-price purchase order to ChemoMetec, Inc. for annual preventative maintenance and service support of seventeen ChemoMetec NC-202 instruments, with a response deadline of August 13, 2026. Work is performed at the NIH Clinical Center in Bethesda, Maryland.
The NC-202 instruments are proprietary analytical devices critical to FDA-regulated cell therapy manufacturing operations conducted by the Center for Cellular Engineering. The contractor must provide annual preventative maintenance, calibration, software updates and patches, inspections, troubleshooting, repair support, replacement of proprietary service parts, and technical support to maintain validated operating conditions across all seventeen instruments. Services are required to sustain compliance with FDA current Good Manufacturing Practice requirements and ensure uninterrupted patient care. The specific instrument serial numbers are identified in the notice.
The sole-source rationale rests on ChemoMetec's proprietary ownership of the NC-202 systems; preventative maintenance, calibration, software updates, diagnostic testing, replacement parts, and technical support require proprietary knowledge and access available only from the manufacturer. This is a pre-solicitation notice; interested parties should monitor for the formal solicitation release and provide comments on the sole-source justification by the August 13 deadline.
Notice text
NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT
Title: Preventative Maintenance/Service Contract for Seventeen (17) ChemoMetec NC-202 Instruments
Notice ID (POTS): 26-007432
Product Service Code (PSC): J066 – Maintenance, Repair, and Rebuilding of Instruments and Laboratory Equipment
NAICS Code: 811210 – Electronic and Precision Equipment Repair and Maintenance
Place of Performance: National Institutes of Health
Clinical Center
Bethesda, MD 20892
Notice
The National Institutes of Health (NIH) Clinical Center intends to award a sole-source firm-fixed-price purchase order to ChemoMetec, Inc. for annual preventative maintenance and service support for seventeen (17) ChemoMetec NC-202 instruments used by the Center for Cellular Engineering (CCE) in FDA-regulated cell therapy manufacturing operations.
Requirement
The NC-202 instruments are critical analytical devices used in the manufacture and testing of patient-specific cell therapies. The contractor shall provide annual preventative maintenance, calibration, software updates and patches, inspections, troubleshooting, repair support, replacement of proprietary service parts, and technical support necessary to maintain validated operating conditions for all seventeen (17) instruments. These services are required to maintain compliance with FDA current Good Manufacturing Practice (cGMP) requirements and ensure uninterrupted patient care.
The serial numbers covered under this action are as follows: 9002020042302432, 9002020042302431, 9002020042302427, 9002020042302422, 9002020042302424, 9002020042302414,9002020042302421, 9002020042302425, 9002020042302426, 9002020042302413, 9002020042302412, 9002020042302435, 9002020042302411,9002020042302436, 9002020042302434, 9002020042302423 and 9002020042302429.
Sole-Source Rationale
The NC-202 instruments are proprietary systems manufactured by ChemoMetec. Preventative maintenance, calibration, software updates, diagnostic testing, replacement parts, and technical support require proprietary tools, software access, and manufacturer-authorized expertise available only from ChemoMetec. Failure to use authorized maintenance services could jeopardize validated manufacturing processes, interrupt patient treatment schedules, increase regulatory risk, and require costly requalification activities.
Authority
The intended sole-source acquisition is authorized under FAR 13.106-1(b)(1)(i), which permits solicitation from a single source when the Contracting Officer determines that only one source is reasonably available for an acquisition not exceeding the Simplified Acquisition Threshold.
Capability Statements
This notice is not a request for quotations or proposals. Responsible sources that believe they can satisfy the Government's requirement may submit a written capability statement. The Government will evaluate all capability statements received; however, the determination not to compete this requirement remains solely within the Government's discretion.
Submission Instructions
Capability statements shall reference POTS 26-007432 and must be submitted electronically no later than August 13, 2026, at 6:00 P.M. Eastern Time (ET).
Point of Contact
Shasheshe Goolsby
Team Leader
Hospital and Laboratory Support Division
Office of Acquisitions and Logistics Management
National Institutes of Health
Email: shasheshe.goolsby@nih.gov
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity